We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

Patrick Trucchio has given his Buy rating due to a combination of factors that highlight the promising potential of Mind Medicine’s MM120 treatment. The company is advancing MM120, a ...

Mind Medicine (MindMed) has dosed the first subject in the Phase III Panorama study of a proprietary form of lysergide D-tartrate (LSD), MM120 orally disintegrating tablets (ODT), for the ...

Mind Medicine (MNMD) announced that the first patient has been dosed in Panorama, its second Phase 3 study evaluating MM120 ODT, a proprietary, pharmaceutically optimized form of LSD for the ...

After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...

In another inflection point for the psychedelic medicines category, Mind Medicine (MindMed) has claimed breakthrough status from the FDA for its LSD-based candidate MM120 as a treatment for anxiety.

Shares of Mind Medicine Inc. (MNMD) surged more than 15% Friday afternoon, on track for their best session since April 2024, ...

Voyage is the first of two Phase 3 studies in GAD evaluating the efficacy and safety of MM120 ODT Business Wire • last month MindMed Scientific Presentations at American College of ...

And, in March 2024, the FDA granted breakthrough designation for Mind Medicines (MindMed), MM120, (LSD D-tartrate) for the treatment of generalised anxiety disorder (GAD). In April 2024 ...

MM120 ODT uses Catalent’s Zydis ODT technology. Credit: MindMed Inc./Business Wire. Mind Medicine (MindMed) has dosed the first subject in the Phase III Panorama study of a proprietary form of ...

Fort St. Lucie, FL (February 22, 2025) – A vehicle crash with injuries occurred on I-95 SB at Mile Marker 120 in St. Lucie County on Saturday night. The accident was reported at 10:14 p.m., prompting ...